lidoflazine has been researched along with Myocardial Ischemia in 4 studies
Lidoflazine: Coronary vasodilator with some antiarrhythmic action.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Animals in groups 4 and 8 were given both lidoflazine and ketanserin according to the dosing schedules above." | 1.27 | Preservation of the ischemic canine myocardium: a comparison of hypothermia, lidoflazine, and ketanserin. ( Clark, NJ; McJames, SW; Pace, NL; Port, JD; Stanley, TH; Stockham, RJ, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, NJ | 1 |
| Port, JD | 1 |
| McJames, SW | 1 |
| Stockham, RJ | 1 |
| Stanley, TH | 1 |
| Pace, NL | 1 |
| Flameng, W | 2 |
| Grover, GJ | 1 |
| Sleph, PG | 1 |
| Chang-Chun, C | 1 |
| Masuda, M | 1 |
| Szabò, Z | 1 |
| Szerafin, T | 1 |
| Szècsi, J | 1 |
| Van Belle, H | 1 |
1 review available for lidoflazine and Myocardial Ischemia
| Article | Year |
|---|---|
Intermittent ischemia of the heart.
Topics: Adenosine; Aorta; Coronary Artery Bypass; Coronary Disease; Coronary Vessels; Humans; Lidoflazine; M | 1995 |
3 other studies available for lidoflazine and Myocardial Ischemia
| Article | Year |
|---|---|
Preservation of the ischemic canine myocardium: a comparison of hypothermia, lidoflazine, and ketanserin.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Cardiopu | 1988 |
The cardioprotective effects of R 75231 and lidoflazine are not caused by adenosine A1 receptor activation.
Topics: Animals; Coronary Circulation; Heart; Lidoflazine; Male; Myocardial Ischemia; Piperazines; Rats; Rat | 1994 |
Nucleoside transport inhibition mediates lidoflazine-induced cardioprotection during intermittent aortic crossclamping.
Topics: Adenosine; Aminophylline; Animals; Aorta; Biological Transport; Blood Pressure; Cardiac Output; Card | 1992 |